PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10148393

Percutaneous mitral valvuloplasty.

F Alfonso·C Macaya
View original source ↗Export metadata ↓

Abstract

The widespread use of percutaneous mitral valvuloplasty on the basis of gained experience, technical advances, and a thorough understanding of its pathophysiologic consequences, has generated great clinical enthusiasm and stimulated research efforts. Recent reports provide new insights into a number of topics, including technical issues, the current value of noninvasive techniques, and the results obtained with mitral valvuloplasty in particular clinical and anatomic settings. This review examines the information provided by recent studies.

Explore related subjects

CatheterizationEchocardiographyHemodynamicsHumansMitral Valve InsufficiencyMitral Valve StenosisJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Alfonso, C Macaya. 1993. Percutaneous mitral valvuloplasty.. https://doi.org/10.1097/00001573-199303000-00007

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes.

Immune heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin. It can result from any type of heparin exposure and by any route of administration; however only a few cases are reported after exposures to small quantities of heparin from catheter flushes. The major clinical problem associated with HIT is thrombosis. Early detection and institution of alternative, non-heparin anticoagulation are important. We report a patient with HIT associated with use of therapeutic-dose unfractionated heparin in whom immune sensitization to heparin was triggered by two 500-unit exposure to UFH associated with intravascular catheter flushing for antineoplastic chemotherapy in a patient with colon adenocarcinoma.

Catheterization↗